P00740 (FA9_HUMAN) Homo sapiens (Human)
Coagulation factor IX UniProtKBInterProSTRINGInteractive Modelling
461 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
45 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of the antithrombin-factor IXa-pentasaccharide complex |
Heteromer P01008; | 2×NAG; 1×NAG; 1×Z9L; 1×CA; 2×MPD; | ||||
| Assess | ||||||
| Anti-FIXa Fab of mim8 in complex with human FIXa |
Heteromer | 17×SO4; 1×0GJ; 1×CA; | ||||
| Assess | ||||||
| factor IXa superactive triple mutant |
Heteromer | 1×CA; 2×1PE; | ||||
| Assess | ||||||
| factor IXa superactive triple mutant, NaCl-soaked |
Heteromer | 1×CA; | ||||
| Assess | ||||||
| factor IXa superactive triple mutant, EDTA-soaked |
Heteromer | |||||
| Assess | ||||||
| factor IXa superactive double mutant |
Heteromer | 1×CA; | ||||
| Assess | ||||||
| factor IXa superactive mutant, EGR-CMK inhibited |
Heteromer | 1×CA; | ||||
| Assess | ||||||
| factor IXa superactive triple mutant, ethylene glycol-soaked |
Heteromer | 1×CA; 1×EDO; | ||||
| Assess | ||||||
| Anti-FIXa Fab in complex with human des-(Gla-EGF1) FIXa |
Heteromer | 2×SO4; 1×TRS; 1×CA; 1×0GJ; | ||||
| Assess | ||||||
| Crystal structure of human factor IX Gla domain in complex of an inhibitory antibody, 10C12 |
Heteromer | 1×SO4; 6×CA; | ||||
| Assess | ||||||
| Crystal structure of Drosophila Poglut1 (Rumi) complexed with its substrate protein (EGF repeat) |
Heteromer Q8T045; | 1×GOL; 6×SO4; | ||||
| Assess | ||||||
| Crystal structure of Drosophila Poglut1 (Rumi) complexed with its substrate protein (EGF repeat) an… |
Heteromer Q8T045; | 1×UDP; 1×GOL; 5×SO4; | ||||
| Assess | ||||||
| Crystal structure of Drosophila Poglut1 (Rumi) complexed with its glycoprotein product (glucosylate… |
Heteromer Q8T045; | 1×UDP; 5×SO4; 1×BGC; | ||||
| Assess | ||||||
| Crystal structure of mouse Xyloside xylosyltransferase 1 complexed with manganese,acceptor ligand a… |
Heteromer Q3U4G3; | 1×BGC; 1×MN; 1×UPG; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of mouse Xyloside xylosyltransferase 1 complexed with manganese, product ligand a… |
Heteromer Q3U4G3; | 1×BGC; 1×MN; 1×UDP; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of mouse Xyloside xylosyltransferase 1 complexed with manganese,acceptor ligand a… |
Heteromer Q3U4G3; | 1×BGC; 1×MN; 1×UDX; | ||||
| Assess | ||||||
| Crystal structure of mouse Xyloside xylosyltransferase 1 complexed with manganese, product ligand a… |
Heteromer Q3U4G3; | 1×BGC; 1×MN; 1×UDP; 1×SO4; | ||||
| Assess | ||||||
| crystal structure of mouse Xyloside xylosyltransferase 1 complexed with manganese, acceptor ligand … |
Heteromer Q3U4G3; | 1×BGC; 1×MN; 1×UDP; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of mouse Xyloside xylosyltransferase 1 complexed with manganese, product ligand a… |
Heteromer Q3U4G3; | 1×BGC; 1×MN; 1×UDP; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of mouse Xyloside xylosyltransferase 1 complexed with acceptor ligand |
Heteromer Q3U4G3; | 1×BGC; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXa | homo-8-mer | 24×SO4; 8×EDO; 4×FMT; 4×PBZ; 4×CA; 4×NA; 12×CL; | ||||
| Assess | ||||||
| Rapid development of two Factor IXa inhibitors from Hit to Lead | homo-2-mer | 1×4K6; 1×NA; 1×NHE; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of EGRCK-inhibited Gla-domainless fIXa (K148Q, R150Q variant) | homo-2-mer | 1×B3P; 1×CA; 10×GOL; | ||||
| Assess | ||||||
| Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors | homo-2-mer | 1×7GQ; 1×NA; 1×NHE; | ||||
| Assess | ||||||
| Rapid development of two Factor IXa inhibitors from Hit to Lead | homo-2-mer | 1×4LN; 1×NA; 1×NHE; 1×CL; | ||||
| Assess | ||||||
| Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors | homo-2-mer | 1×UNL; 1×NA; 2×NHE; | ||||
| Assess | ||||||
| Development of a novel tricyclic class of potent and selective FIXa inhibitors | homo-2-mer | 1×NA; 1×NHE; 1×5NY; | ||||
| Assess | ||||||
| Benzothiophene Inhibitors of Factor IXa | homo-2-mer | 2×IYX; 1×CA; | ||||
| Assess | ||||||
| Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors | homo-2-mer | 2×GOL; 1×6NH; 1×NA; 4×CIT; | ||||
| Assess | ||||||
| Selective Benzothiophine Inhibitors of Factor IXa | homo-2-mer | 1×CA; 1×IZX; | ||||
| Assess | ||||||
| HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE | homo-2-mer | 1×CA; 1×PBZ; 1×TBU; | ||||
| Assess | ||||||
| Development of a novel class of potent and selective FIXa inhibitors | homo-2-mer | 1×4M1; 1×NA; 1×NHE; | ||||
| Assess | ||||||
| Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors | homo-2-mer | 1×UQD; 4×CIT; 2×GOL; | ||||
| Assess | ||||||
| Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors | homo-2-mer | 1×UQG; 1×NA; 4×CIT; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of factor IXa K98T variant in complex with PPACK | homo-2-mer | 1×0G6; 1×CA; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of factor IXa variant V16I K98T Y177T I212V in complex with PPACK | homo-2-mer | 1×CA; 1×0G6; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of factor IXa variant K98T in complex with EGR-chloromethylketone | homo-2-mer | 1×CA; 1×0GJ; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with EGR-chloromethylketone | homo-2-mer | 1×CA; 1×0GJ; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of factor IXa variant V16I K98T Y177T I213V in complex with PPACK | homo-2-mer | 1×CA; 1×0G6; | ||||
| Assess | ||||||
| EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX | homo-2-mer | 3×CA; | ||||
| Assess | ||||||
| STRUCTURE OF THE METAL-FREE GAMMA-CARBOXYGLUTAMIC ACID-RICH MEMBRANE BINDING REGION OF FACTOR IX BY… | monomer | 12×FMT; | ||||
| Assess | ||||||
| NMR STRUCTURE OF CALCIUM ION-BOUND GAMMA-CARBOXY-GLUTAMIC ACID-RICH DOMAIN OF FACTOR IX | monomer | |||||
| Assess | ||||||
| COAGULATION FACTOR, MG(II), NMR, 7 STRUCTURES (BACKBONE ATOMS ONLY) | monomer | |||||
| Assess | ||||||
| Crystal structure of hFA9 EGF repeat with O-glucose trisaccharide | monomer | 1×BGC; 2×CA; | ||||
| Assess | ||||||
| THE THREE-DIMENSIONAL STRUCTURE OF THE FIRST EGF-LIKE MODULE OF HUMAN FACTOR IX: COMPARISON WITH EG… | monomer | |||||
| Assess | ||||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3h5c.1.B | monomer | 0.57 | 30.45 | |||
| Assess | ||||||
| 5edm.1.A | monomer | 0.55 | 34.06 | |||
| Assess | ||||||
| 4o03.1.A | monomer | 0.53 | 33.58 | |||
| Assess | ||||||
| 5edk.1.A | monomer | 0.52 | 33.58 | |||
| Assess | ||||||
3 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4bxs.1.A | monomer | 0.60 | 44.76 | ||
| Assess | ||||||
| Isoform 2 | 4o03.1.A | monomer | 0.54 | 1×CA; | 34.76 | |
| Assess | ||||||
| Isoform 2 | 5edk.1.A | monomer | 0.52 | 34.76 | ||
| Assess | ||||||